- Home
- CVAC vs CDRE Comparison
CVAC vs CDRE Comparison
Compare CVAC & CDRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- CDRE
- Stock Information
- Founded
- CVAC 2000
- CDRE 2012
- Country
- CVAC Germany
- CDRE United States
- Employees
- CVAC N/A
- CDRE N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- CDRE Industrial Specialties
- Sector
- CVAC Health Care
- CDRE Health Care
- Exchange
- CVAC Nasdaq
- CDRE Nasdaq
- Market Cap
- CVAC 1.2B
- CDRE 1.3B
- IPO Year
- CVAC 2020
- CDRE 2021
- Fundamental
- Price
- CVAC $5.48
- CDRE $29.24
- Analyst Decision
- CVAC Hold
- CDRE Buy
- Analyst Count
- CVAC 3
- CDRE 2
- Target Price
- CVAC $6.83
- CDRE $31.50
- AVG Volume (30 Days)
- CVAC 789.9K
- CDRE 384.5K
- Earning Date
- CVAC 08-18-2025
- CDRE 08-05-2025
- Dividend Yield
- CVAC N/A
- CDRE 1.29%
- EPS Growth
- CVAC N/A
- CDRE N/A
- EPS
- CVAC 0.87
- CDRE 0.93
- Revenue
- CVAC $566,039,775.00
- CDRE $572,607,000.00
- Revenue This Year
- CVAC N/A
- CDRE $13.31
- Revenue Next Year
- CVAC $24.04
- CDRE $7.96
- P/E Ratio
- CVAC $6.35
- CDRE $31.57
- Revenue Growth
- CVAC 787.60
- CDRE 7.66
- 52 Week Low
- CVAC $2.37
- CDRE $27.07
- 52 Week High
- CVAC $5.72
- CDRE $40.28
- Technical
- Relative Strength Index (RSI)
- CVAC 60.60
- CDRE 40.28
- Support Level
- CVAC $5.41
- CDRE $28.22
- Resistance Level
- CVAC $5.54
- CDRE $31.25
- Average True Range (ATR)
- CVAC 0.05
- CDRE 1.54
- MACD
- CVAC -0.01
- CDRE -0.36
- Stochastic Oscillator
- CVAC 73.68
- CDRE 15.60
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About CDRE Cadre Holdings Inc.
Cadre Holdings Inc is engaged in the design and manufacture of a diversified product portfolio of critical safety and survivability equipment to protect first responders, federal agencies, outdoor recreation, and personal protection markets. The Company's equipment provides critical protection to allow its users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. Its operations are comprised of two reportable segments: Products and Distribution.